Acupuncture Trial for Heel Pain Syndrome Shows Promise in Pain Relief and Function
A randomized controlled trial is evaluating the efficacy of acupuncture at the Heel Pain Point for treating heel pain syndrome, comparing it to manual therapy and sham acupuncture.
Phase III
Pain Management / Acupuncture
Status
Active
Sponsor
pharma companies in pain management
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing trial evaluating acupuncture for heel pain syndrome could redefine treatment paradigms in pain management. If successful, it may challenge conventional therapies and necessitate a reevaluation of competitive strategies for pharma companies involved in this therapeutic area.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor the trial's primary endpoint results, particularly the pain response rate and functional recovery metrics at follow-up visits.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.